Ventyx Biosciences, Inc. (VTYX) Stock Analysis
DELISTED 2026
What happened to Ventyx Biosciences, Inc. (VTYX) stock?
Ventyx Biosciences, Inc. (VTYX) no longer trades on public markets. It was delisted in March 2026. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- March 2026
- Last recorded price (historical):
- $14.00 (last quote on record before the March 2026 delisting; historical, not a current quote)
Market cap $1.00B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Ventyx Biosciences, Inc. (VTYX). Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates for inflammatory diseases and autoimmune disorders. Their lead product candidate, VTX958, is currently in phase I clinical trials.
Last analyzed: May 4, 2026Ventyx Biosciences, Inc. (VTYX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy VTYX shares?
No. VTYX stopped trading on public markets in March 2026, so the shares are not available through a broker. Anything you see quoted for VTYX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before VTYX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Ventyx Biosciences, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.